Beginning to increase voices that point to Coca-Cola is in talks with the Canadian company Aurora Cannabis for the development of a new drink.
According to an article from the Bloomberg agency, Cola-Cola would be interested in using CBD in the development of new beverages.
It must be clarified that CBD is the medicinal component of cannabis that does not cause psychotropic effects in those who consume it.
That is why every time it is seen by companies as an interesting ingredient to study and with which to experiment.
There are different studies that ensure the broad scope of CBD for the treatment of many diseases, given their medicinal and therapeutic potentials: antioxidant, anti-psychotic and anxiolytic effects.
Precisely at this point is where Coca-Cola will be working on how to include in its formula this ingredient to use the medicinal benefits of cannabidiol (CBD) to offer a healthy “recovery” product for the consumer.
“They are quite advanced in this regard,” BNN source Bloomberg reported. “It’s going to be more of the recovery drink category.”
The possible agreement between the multinational and local producer Aurora Cannabis would make Coca-Cola the first large manufacturer of soft drinks to enter the cannabis market. However, both companies remain silent on this issue for the time being.
According to BNN Bloomberg (its anonymous source), Aurora is not the first cannabis company to which Coca-Cola has approached to develop a strategy on cannabis, and there are no guarantees that these talks will succeed. But with the company’s recent desire to diversify its portfolio, analysts say the move to the cannabis sector is not surprising.
“Coca-Cola said in a somewhat cryptic statement on the subject. “No decision has been made at this time,” he added.
It should be noted that the scene of this news is Canada, the first G20 country to legalize marijuana for recreational purposes. Free and the production of cannabis will be legal as of October 17.
